ProShares UltraShort TIPs TPS
Set alert
At close · Jun 28
- Open
- 24.18
- Prev close
- 24.18
- Mkt cap
- 0
- Vol
- 313
- Avg vol
- 26.00K
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 24.18
- High
- 24.18
- Forward P/E
- 0.00
- Beta
- 0.00
- Short ratio
- 0.00
- Inst. own
- 0.00%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 0.00
- 200-d avg
- 0.00
- 1y target
- 0.00
News
1 week ago gurufocus.com
Merck and Moderna Will Present Results From Landmark Phase 3 INTerpath-001 Trial for Intismeran Autogene Plus KEYTRUDA® (pembrolizumab) at ESMO 2026 Presidential Symposium
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, and Moderna, Inc. (NASDAQ: MRNA) today announced detailed positive recurrence-free surv
1 month ago gurufocus.com
Merck Receives Positive EU CHMP Opinion for KEYTRUDA® (pembrolizumab) Plus Padcev® (enfortumab vedotin-ejfv) as Perioperative Treatment for Adults With Resectable Muscle-Invasive Bladder Cancer (MIBC)
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the European Medicines Agency's Committee for Medicinal Products for Hu
1 month ago gurufocus.com
Accuray and RaySearch Agree to Collaboration Integrating RayStation Software with Accuray Platforms to Accelerate Accuray's Online Adaptive Capabilities
Accuray and RaySearch Agree to Collaboration Integrating RayStation Software with Accuray Platforms to Accelerate Accuray's Online Adaptive CapabilitiesPR Newsw
2 months ago zacks.com
Amtech's TPS Drives Revenue Growth: Is the Trend Set to Continue?
ASYS' TPS revenues jump 24.9% as AI-related sales surge, while strong bookings and orders point to more growth ahead.
5 months ago gurufocus.com
FDA Grants Breakthrough Therapy Designation for Calderasib (MK-1084), an Investigational KRAS G12C Inhibitor, for Certain Patients with Newly Diagnosed Metastatic KRAS G12C-Mutant Non-Small Cell Lung
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced that calderasib (MK-1084), an investigational oral specific KRAS G12C inhibi
5 months ago gurufocus.com
Leidos to Accelerate Hypersonic Weapons Production for U.S. Army and Navy
Leidos to Accelerate Hypersonic Weapons Production for U.S. Army and Navy PR Newswire RESTON, Va., May 12, 2026
9 months ago seekingalpha.com
Technip Energies: Positioned To Win Across Energy Cycles
Technip Energies is upgraded to 'buy' based on robust LNG project execution, strong cash flow, and relative undervaluation versus peers. THNPY's TPS segment provides high-margin, recurring revenues,…
3 years ago rawstory.com
Video shows argument that led up to fatal shooting outside high school
One person was killed and another sent to hospital after shooting broke out outside Woburn Collegiate Institute in Scarborough, Toronto, CP24 reports. One person was found with gunshot wounds and was…
4 years ago headlinesoftoday.com
ViewTech Borescopes Exhibiting at The Battery Show, IMTS, and Turbomachinery & Pump Symposia
TRAVERSE City, Mich., Sept. 8, 2022 (SEND2PRESS NEWSWIRE) — ViewTech Borescopes is set to network with attendees as they assemble this month at The Battery Show, International Manufacturing…
4 years ago aljazeera.com
Biden administration extends TPS protection for Venezuelans
Temporary Protect Status extension shields Venezuelans in US as of March 2021 from deportation for 18 more months...
4 years ago headlinesoftoday.com
Automotive eCall Market to Reach 5.22 Million Units Globally by 2025 at 2.86% CAGR | Technavio
NEW YORK, July 7, 2022 /PRNewswire/ — The “Automotive eCall Market by Technology (standard installation and TPS installation) and Geography (Europe, N...